Report by Chief Executive.
3
There was submitted a report by the Chief Executive relative to the Advanced Manufacturing Innovation District (AMIDS) and the next phase of development together with an update on the ongoing work on the Glasgow City Region Investment Zone.
The report stated that the Advanced Manufacturing Innovation District Scotland (AMIDS) was intended to become ‘Scotland’s home of manufacturing innovation’. The site, located next to Glasgow Airport, was supported by new enabling infrastructure in the form of roads, bridges, utilities, public realm space and active travel connections all funded by the Glasgow City Region City Deal. The concept of AMIDS was to deliver a world class innovation district with the objective of positively enhancing the economy of both Renfrewshire and Scotland as whole. The report advised that this would be achieved through collaborative working between the education, public, and private sectors. Creating a focus on advanced manufacturing at the district would enable a cluster effect to be generated, in turn, attracting global organisations to Renfrewshire. AMIDS had successfully established itself in the advanced manufacturing sector by securing two anchor tenants, The National Manufacturing Institute Scotland (NMIS) and the Medicines Manufacturing Innovation Centre (MMIC). The Council had entered into a joint venture with Buccleuch Property to progress the next phases of development on site. This agreement set out that a speculative build required to take place which would see the construction of two terraced units that encompassed ten individual units offering space at the optimal size for start-up or spinoff companies. The construction was planned for completion in 2026 and work was well advanced in terms of design, which would be followed by the planning permission process and subsequently procurement of a construction contractor. The advantages of employing this approach were outlined within the report.
The report highlighted the recent announcement that CPI, who operated MMIC, would be extending their development at AMIDS to deliver the Oligonucleotide Manufacturing Innovation Centre of Excellence (OMICE). This multi-million pound investment would see a second unit constructed to ensure that Renfrewshire and Scotland were at the forefront of medicines innovation. The development would be the next physical construction to complete on site and showed the confidence that the industry had in AMIDS to succeed.
A summary of the benefits of the AMIDS Support Model was provided within the report, together with the key dimensions to the development AMIDS. It was highlighted that to achieve the two key dimensions a wide network of support had been implemented including the establishment of the joint venture, supported by a Strategic Advisory Group consisting of senior/executive staff from organisations including the Council, Scottish Government, Scottish Enterprise, NMIS, CPI (MMIC / OMICE), Skills Development Scotland, West College Scotland and University of Strathclyde. In addition, it was noted that during 2022, a report by the University of Strathclyde and CPI had established that AMIDS had greatest potential, from a skills and innovation perspective, to target the Space, Pharma, Photonics and Net Zero sectors. Whilst AMIDS was open for all sectors, a focus on the four aforementioned sectors had allowed key partner organisations to provide subject matter experts to assist with market engagement. It was also recognised that due to the specialist technical nature of advanced manufacturing, expert advice would assist in negotiation as well as the provision of advice in relation to requirements, support models, and partnership working. The report made reference to the award of Investment Zone status to the Glasgow City Region area, the potential opportunities and benefits, a summary of details of a proposed bid submission by the Council in respect of the Netherton Campus together with a information regarding communications and marketing initiatives being employed.
DECIDED:
(b) That the progress at AMIDS and the joint working with external agencies and partners to secure the next phases of investment be noted; and
(b) That the proposed submission, as outlined in paragraph 7 of the report be noted and that it also be noted that regular updates and required approvals would be submitted to this Policy Board as appropriate.